相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
Guy A. Cabral et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
Christopher M. Henstridge et al.
FASEB JOURNAL (2009)
2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55
Saori Oka et al.
JOURNAL OF BIOCHEMISTRY (2009)
Endocannabinoid signaling in microglial cells
Nephi Stella
NEUROPHARMACOLOGY (2009)
The therapeutic potential of novel cannabinoid receptors
Faith R. Kreitzer et al.
PHARMACOLOGY & THERAPEUTICS (2009)
The enigmatic pharmacology of GPR55
Ruth A. Ross
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
CB2 receptors in the brain: role in central immune function
G. A. Cabral et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Interferon-γ Is a Critical Modulator of CB2 Cannabinoid Receptor Signaling during Neuropathic Pain
Ildiko Racz et al.
JOURNAL OF NEUROSCIENCE (2008)
The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain
Penny C. Staton et al.
PAIN (2008)
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Jane E. Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
D. G. Johns et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
Uwe-Karsten Hanisch et al.
NATURE NEUROSCIENCE (2007)
Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine
Devorah Matas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: Involvement of NF-kappa B and ERK signaling pathways
Jin-Sun Park et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Chronic exposure to Δ9-tetrahydrocannabinol downregulates oxytocin and oxytocin-associated neurophysin in specific brain areas
E Butovsky et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2006)
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
K Maresz et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Evidence for novel cannabinoid receptors
M Begg et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Cannabinoid-based drugs as anti-inflammatory therapeutics
TW Klein
NATURE REVIEWS IMMUNOLOGY (2005)
Prevention of Alzheimer's disease pathology by cannabinoids:: Neuroprotection mediated by blockade of microglial activation
BG Ramírez et al.
JOURNAL OF NEUROSCIENCE (2005)
Cannabinoids and neuroinflammation
L Walter et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
被撤回的出版物: c-Src is activated by the epidermal growth factor receptor in a pathway that mediates JNK and ERK activation by gonadotropin-releasing hormone in COS7 cells (Retracted article. See vol. 292, pg. 8851, 2017)
S Kraus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Molecular insights on the cerebral innate immune system
S Rivest
BRAIN BEHAVIOR AND IMMUNITY (2003)
Cannabinoids and multiple sclerosis
RG Pertwee
PHARMACOLOGY & THERAPEUTICS (2002)
Astrocytes in culture produce anandamide and other acylethanolamides
L Walter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation
SJ Carlisle et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
分享论文
